stock
Nasus Pharma Ltd.
NYSE MKT | NSRX
7.00
USD
+$0.00
(+0.00%
)At Close (As of Nov 20, 2025)
-
Market Cap
-
P/E Ratio
-
EPS
$9.99
52 Week High
$0.00
52 Week Low
HEALTHCARE
Sector
NSRX Chart
Recent Chart
Price Action
NSRX Technicals
NSRX Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $717K |
| Total Current Assets | $457K |
| Cash And Cash Equivalents At Carrying Value | $284K |
| Cash And Short Term Investments | $284K |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $260K |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $146K |
| Other Non Current Assets | - |
| Total Liabilities | $3.9M |
| Total Current Liabilities | $3.9M |
| Current Accounts Payable | $651K |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | - |
| Total Non Current Liabilities | $0 |
| Capital Lease Obligations | - |
| Long Term Debt | - |
| Current Long Term Debt | $1.8M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | - |
| Other Current Liabilities | $489K |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | -$3.2M |
| Treasury Stock | - |
| Retained Earnings | -$13M |
| Common Stock | - |
| Common Stock Shares Outstanding | $9.1M |
NSRX Profile
Nasus Pharma Ltd. Profile
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - GENERAL
Nasus Pharma Ltd. is a clinical-stage specialty pharmaceutical company based in Tel Aviv-Yafo, Israel, that specializes in developing innovative intranasal drug formulations for critical emergency medical conditions. Leveraging its proprietary drug delivery technology, the company seeks to enhance treatment efficacy and patient compliance, particularly in urgent care scenarios. With a strong pipeline of products in development, Nasus Pharma is poised to become a leader in the rapidly evolving intranasal therapeutics market, emphasizing patient-centric solutions and improved healthcare outcomes. The company's strategic focus on innovation positions it to address significant unmet medical needs, making it an attractive opportunity for institutional investors.
LPTX +368.57%
$2.05
SOND +79.15%
$0.16
BNKK
+19.70%
$0.17
NVDA -3.15%
$180.64
IVP +18.43%
$0.12
VHAI -50.00%
$0.00
ONDS -16.40%
$6.27
TSLA -2.16%
$395.23
WTO -14.65%
$0.01
ASST -6.40%
$0.98
BYND -9.80%
$0.88
PLUG -0.52%
$1.89
F -3.79%
$12.41
SOFI -6.77%
$24.91
INTC -4.24%
$33.62
SGBX -36.46%
$3.85
CIFR -0.41%
$14.56
GRAB -6.21%
$4.98
BITF 0.00%
$2.60
NWTN +41.76%
$0.78
PLTR -5.84%
$155.74
AIIO
+41.76%
$0.78
DNN -4.52%
$2.32
WULF -5.47%
$11.56
ACHR -8.03%
$6.87
NIO -6.08%
$5.40
MNDR +83.13%
$3.04
AXDX -61.36%
$0.03
AMD -7.84%
$206.02
AUID +5.55%
$1.71
IREN -5.14%
$43.47
GOOGL -1.14%
$289.45
EXAS +17.13%
$100.94
AAL -0.72%
$12.24
NOK -2.65%
$5.87
MARA -7.74%
$10.24
DVLT +8.75%
$1.74
RGTI -10.44%
$22.80
BMNR
-9.00%
$26.55
SOUN -2.92%
$11.29
PFE -1.92%
$24.40
ADAP -15.14%
$0.05
AMZN -2.49%
$217.14
WMT +6.46%
$107.11
MU -10.86%
$201.37
WBD -0.90%
$22.88
CHR -7.57%
$0.05
AAPL -0.86%
$266.25
SNAP -3.11%
$7.78
RIG -6.34%
$3.84
EOSE +0.78%
$12.88
PLTD +5.82%
$7.63
ABEV -1.61%
$2.43
T +0.98%
$25.52
RIVN -0.44%
$14.65
TLRY -6.53%
$0.89
BBWI -24.80%
$15.82
QBTS -12.58%
$20.49
AZI -18.11%
$0.06
BURU
-10.49%
$0.18
CRWV
-7.62%
$69.21
RMBL +60.50%
$3.21
NFE +25.86%
$1.46
LNW -3.71%
$86.22
ADD -25.47%
$0.05
CAN -4.08%
$0.92
SMCI -6.43%
$31.56
APLD -7.57%
$21.34
BAC -1.96%
$51.00
NFLX -3.93%
$105.67
RXRX -4.20%
$3.86
CYPH
0.00%
$2.94
BTBT -5.09%
$2.05
SRM +53.27%
$10.30
GOOG -1.02%
$289.98
NBIS -10.97%
$84.64
IONZ
+28.40%
$6.42
QUBT -11.15%
$10.27
PCG +0.66%
$15.82
NVVE -15.67%
$0.16
BTG -4.53%
$3.79
BULL
+0.36%
$8.25
IONQ -14.39%
$40.99
NVTS -2.20%
$7.55
VZ -1.04%
$40.76
LEN +0.94%
$116.25
PLTZ
+11.57%
$8.48
SMR -11.57%
$18.68
LAES -7.86%
$3.63
RZLV -0.66%
$2.99
VALE -1.81%
$11.90
BTE -0.62%
$3.16
HBAN -0.39%
$15.32
BBD -1.66%
$3.54
CGC -3.80%
$1.01
AVGO -2.14%
$346.82
WLGS -5.57%
$0.04
BMNU
-22.39%
$5.37
WKHS +28.34%
$0.93
MTSR -0.35%
$70.50
LPTX +368.57%
$2.05
SOND +79.15%
$0.16
BNKK
+19.70%
$0.17
NVDA -3.15%
$180.64
IVP +18.43%
$0.12
VHAI -50.00%
$0.00
ONDS -16.40%
$6.27
TSLA -2.16%
$395.23
WTO -14.65%
$0.01
ASST -6.40%
$0.98
BYND -9.80%
$0.88
PLUG -0.52%
$1.89
F -3.79%
$12.41
SOFI -6.77%
$24.91
INTC -4.24%
$33.62
SGBX -36.46%
$3.85
CIFR -0.41%
$14.56
GRAB -6.21%
$4.98
BITF 0.00%
$2.60
NWTN +41.76%
$0.78
PLTR -5.84%
$155.74
AIIO
+41.76%
$0.78
DNN -4.52%
$2.32
WULF -5.47%
$11.56
ACHR -8.03%
$6.87
NIO -6.08%
$5.40
MNDR +83.13%
$3.04
AXDX -61.36%
$0.03
AMD -7.84%
$206.02
AUID +5.55%
$1.71
IREN -5.14%
$43.47
GOOGL -1.14%
$289.45
EXAS +17.13%
$100.94
AAL -0.72%
$12.24
NOK -2.65%
$5.87
MARA -7.74%
$10.24
DVLT +8.75%
$1.74
RGTI -10.44%
$22.80
BMNR
-9.00%
$26.55
SOUN -2.92%
$11.29
PFE -1.92%
$24.40
ADAP -15.14%
$0.05
AMZN -2.49%
$217.14
WMT +6.46%
$107.11
MU -10.86%
$201.37
WBD -0.90%
$22.88
CHR -7.57%
$0.05
AAPL -0.86%
$266.25
SNAP -3.11%
$7.78
RIG -6.34%
$3.84
EOSE +0.78%
$12.88
PLTD +5.82%
$7.63
ABEV -1.61%
$2.43
T +0.98%
$25.52
RIVN -0.44%
$14.65
TLRY -6.53%
$0.89
BBWI -24.80%
$15.82
QBTS -12.58%
$20.49
AZI -18.11%
$0.06
BURU
-10.49%
$0.18
CRWV
-7.62%
$69.21
RMBL +60.50%
$3.21
NFE +25.86%
$1.46
LNW -3.71%
$86.22
ADD -25.47%
$0.05
CAN -4.08%
$0.92
SMCI -6.43%
$31.56
APLD -7.57%
$21.34
BAC -1.96%
$51.00
NFLX -3.93%
$105.67
RXRX -4.20%
$3.86
CYPH
0.00%
$2.94
BTBT -5.09%
$2.05
SRM +53.27%
$10.30
GOOG -1.02%
$289.98
NBIS -10.97%
$84.64
IONZ
+28.40%
$6.42
QUBT -11.15%
$10.27
PCG +0.66%
$15.82
NVVE -15.67%
$0.16
BTG -4.53%
$3.79
BULL
+0.36%
$8.25
IONQ -14.39%
$40.99
NVTS -2.20%
$7.55
VZ -1.04%
$40.76
LEN +0.94%
$116.25
PLTZ
+11.57%
$8.48
SMR -11.57%
$18.68
LAES -7.86%
$3.63
RZLV -0.66%
$2.99
VALE -1.81%
$11.90
BTE -0.62%
$3.16
HBAN -0.39%
$15.32
BBD -1.66%
$3.54
CGC -3.80%
$1.01
AVGO -2.14%
$346.82
WLGS -5.57%
$0.04
BMNU
-22.39%
$5.37
WKHS +28.34%
$0.93
MTSR -0.35%
$70.50